MedTech Dive July 20, 2021
Dive Brief:
- After a sluggish first quarter, investment in medical device makers roared back in April through June to hit $8.2 billion, with early-stage startups among the biggest beneficiaries, according to a new report from CB Insights, whose research focuses on equity rounds to private healthcare companies.
- Late-stage funding kept pace with the prior quarter: Robot manufacturer CMR Surgical’s $600 million round and portable dialysis system maker Quanta Dialysis Technologies’ $245 million Series D deal led the category.
- Diabetes tech developers Fractyl Health and CeQur and pathology software startups CellsVision, Aiforia and PathAI also garnered fresh backing from investors.
Dive Insight:
The global healthcare sector attracted equity investment throughout the pandemic, and it is still pouring in. The...
Today's Sponsors
Today's Sponsor